Sherrol A. Reynolds, OD, FAAO, FNAP, identifies patients who are most at risk for geographic atrophy and provides clinicians with guidance for managing the vision-threatening disorder and referring for treatment.

Jan 17, 2025 · Prior to launching perfluorohexyloctane, prescription dry eye treatments were aimed at reducing inflammation and increasing tear production. Even though targeting these areas can be beneficial, they do not specifically address the evaporative component of DED. 5 Perfluorohexyloctane, however, not only treats both the signs and symptoms of dry eye, but targets this element, which previous ...

5 hours ago · A monthly toric contact lens can provide frequent digital device users with a comfortable wearing experience, according to a study published in Clinical Optometry. Although patients fit with these lenses do report a decrease in comfort throughout the day, few report that the lenses ultimately become uncomfortable by the day’s end, the report shows.

Nov 1, 2024 · Axial Elongation in Adult Myopia . Regular eye exams are important for all adults, particularly those experiencing myopia progression. During these visits, it is important for clinicians to measure axial length, due to its association with pathologic myopia. 3 An optical biometer can best measure axial length changes, but not all practices have one. . Among optometry practices that do utilize ...

Jan 15, 2025 · In the last month, the US Food and Drug Administration (FDA) has approved a visual field analyzer that uses only objective parameters to determine visual field loss, cleared a mapping and data module for a corneal optical coherence tomography (OCT) device, granted rare pediatric disease designation for a novel gene therapy for inherited retinal dystrophy, and approved a generic equivalent for ...

Dec 15, 2023 · Treatments were decided based on the results of this data analysis and patients were monitored every 3 to 6 months for progression, which was defined as 0.25 D or greater myopia spherical equivalent progression (as assessed with cycloplegic autorefraction) or greater than 0.10 mm axial elongation in 6 months. Children who showed progression while on one treatment, received a change in treatment.

Dec 9, 2024 · Drug Regulatory Updates. PL9643: Dry Eye Disease. Palatin Technologies, Inc. has received confirmation from the FDA regarding the acceptability of the protocols and endpoints for signs and symptoms of PL9643 in its phase 3 pivotal clinical trials for dry eye disease (DED). 1 The remaining phase 3 clinical trials, MELODY-2 and MELODY-3, include endpoints related to both signs and symptoms of ...

Oct 4, 2024 · An optometry student can learn a lot in a lab or clinical research setting, but their contact with patients will ultimately guide their clinical decision-making skills and shape their perspectives, according to Andrew Rixon, OD, FAAO, Diplomate (Glaucoma), this year’s recipient of the Vincent Ellerbrock Clinician Educator Award.

Nov 22, 2023 · As optometrists struggle with the demand created by an emerging myopia epidemic, repeated low-level red light therapy may provide an alternative to contact lens wear or atropine treatment for slowing axial progression and spherical equivalent refraction (SER). While the treatment has yet to receive US Food and Drug Administration (FDA) approval, it has demonstrated efficacy in clinical trials ...

Oct 28, 2024 · Binocular highly aspherical lenslets (HALs) can limit axial growth in both the myopic eye and the nonmyopic eye in children with unilateral myopic anisometropia, according to an ambispective, cohort study published in Ophthalmic Physiological Optics.Monocular orthokeratology (ortho-k) treatment, in comparison, can limit limit axial growth in the eye with myopia, leaving the fellow nonmyopic ...